Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 65

Program to help patients with long-term COVID-19 symptoms

Official title: Covid-19 Long Haul Syndrome: Undiagnosed Disorder Post Covid-19 Alternative Treatment Study.

Run by Well- Konnect Healthcare Services and Research Firm · NCT06441955 · Data updated 2026-11-12

This study is testing a program to help people with long-term COVID-19 symptoms by offering treatments and support to see if it can improve their health.

More COVID Long-Haul trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorWell- Konnect Healthcare Services and Research Firm
Research network
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedSeptember 30, 2030
Study endsSeptember 30, 2030
Registry record updatedNovember 27, 2024
Trial IDNCT06441955 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have tested positive for COVID-19 and are experiencing persistent symptoms.

Probably not a fit

Patients with a history of myocarditis, pericarditis, or severe renal impairment may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program focuses on understanding and treating the long-term effects of COVID-19, specifically targeting individuals who have experienced persistent symptoms after their initial infection. It aims to recruit 25 to 100 participants who have tested positive for COVID-19, regardless of their treatment history. The study will involve comprehensive assessments and provide various interventions, including medications and behavioral therapies, to address the core symptoms associated with long-haul COVID-19. Additionally, the program emphasizes diversity in participant recruitment to ensure a wide representation of demographics.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life for patients suffering from long-haul COVID-19 symptoms.

How similar studies have gone: Other studies have explored treatments for long-haul COVID-19, but this program's comprehensive approach and focus on diverse biomarker categories may offer novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inclusion of Men, Women, and Minorities
* Participants must be at least 18 years old.
* Participants must have a positive COVID-19 diagnosis or clinical diagnosis of COVID-19
* Participants must have experienced persistent symptoms after recovering from the acute phase of the illness.
* Participants must be willing to provide informed consent to participate in the study.
* Participants must be able to communicate effectively in English or have a translator available.
* Participants must be able to attend follow-up appointments as required by the study protocol.
* Participants must not have any medical conditions or take any medications that could interfere with the study results.

Exclusion Criteria:

* \>18 years of age
* Medical History of Myocarditis
* Medical History of Pericarditis
* Medical History of Severe renal impairment (eGFR \<30 mL/min).

Where it's running

  • NIH Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Kawana J Williams, Ph.D. — The National Institute of Health All of Us Research Program At Well-Konnect Healthcare Services and Research Center
  • Study coordinator: Kawana J Williams, Ph.D.
  • Email: Kawana.williams@waldenu.edu
  • Phone: 2406201587

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.